Raffles Medical Group Ltd Stock: price and insider trades · Singapore

Raffles Medical Group Ltd is a listed company. Its directors and officers file their transactions with SGX. From 20 October 2025 to 20 October 2026, the disclosure feed for Raffles Medical Group Ltd logged 10 filings by 7 insiders.

Open-market activity splits into 5 purchases totalling €1.8M and 1 sale totalling €218k; 2 insiders sit on the buying side and 1 insider on the selling side. The net balance comes to €1.6M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 2 chief executives. One trade stands out by size: a purchase of €1.2M from Loo Choon Yong, disclosed on 5 March 2026.

Within a 30-day window, 3 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The latest purchase dates back some time: it was published 157 days ago, on 19 May 2026. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade.

Across the 393 companies tracked on its exchange, the median is 6 filings; at 10 filings, this issuer sits above that mark. Since 2017, the database holds 148 purchases and 12 sales by insiders of the company.

This summary is built from SGX disclosures alone and does not predict where the share price will go.